AMGN stock · CLOV stock

AMGN vs CLOV

Amgen Inc (AMGN) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.

Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CLOV currently screens at market cap $1.55B.

Not investment advice. Open the AMGN and CLOV stock pages for the full models.

Not investment advice.

Popular Stock Comparisons